4.7 Article

LINC00857 Interacting with YBX1 to Regulate Apoptosis and Autophagy via MET and Phosphor-AMPKa Signaling

Journal

MOLECULAR THERAPY-NUCLEIC ACIDS
Volume 22, Issue -, Pages 1164-1175

Publisher

CELL PRESS
DOI: 10.1016/j.omtn.2020.10.025

Keywords

-

Funding

  1. Southern University of Science and Technology Starting Foundation
  2. Shenzhen High Level University Building Foundation
  3. National Natural Science Foundation of China (NSFC), China [32070625, 82073388, 81803564, 81871883]
  4. Affiliated Hospital of Guangdong Medical University Doctoral Foundation [2018052638]
  5. China Postdoctoral Science Foundation, China [2018M633619XB]
  6. Center for Computational Science and Engineering of Southern University of Science and Technology

Ask authors/readers for more resources

Long noncoding RNA (lncRNA) LINC00857 has been reported to be upregulated in lung cancer and related to poor patient survival. It can regulate cell proliferation and tumor growth in lung cancer as well as several other cancers. However, the underlying molecular mechanisms that are regulated by LINC00857 are unclear. In this study, we found that LINC00857 silencing can impair cell proliferation in 14 different genomic alterations of lung cancer cell lines. These alterations are EGFR, KRAS, TP53, MET, and LKB1 mutations. The cell apoptosis and autophagy were induced upon LINC00857 silencing in lung cancer cells. Mechanistically, LINC00857 can bind to the Y-box binding protein 1 (YBX1) protein, prevent it from proteasomal degradation, and increase its nuclear translocation. LINC00857 regulated MET expression via YBX1 at a transcriptional level. Induced cell autophagy by LINC00857 knockdown was mainly through increased phosphor-AMP-activated protein kinase (p-AMPK)a. Collectively, LINC00857-YBX1-MET/p-AMPKa signaling is critical to regulate cell proliferation, apoptosis, and autophagy, which may provide a potential clinically therapeutic target in lung cancer.y

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available